Search by Drug Name or NDC
NDC 50419-0482-03 Angeliq .25; .5 mg/1; mg/1 Details
Angeliq .25; .5 mg/1; mg/1
Angeliq is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bayer HealthCare Pharmaceuticals Inc.. The primary component is DROSPIRENONE; ESTRADIOL.
Product Information
| NDC | 50419-0482 |
|---|---|
| Product ID | 50419-482_23b483a9-7331-4d98-be0a-9ce4d37b671f |
| Associated GPIs | 24993002400310 |
| GCN Sequence Number | 069389 |
| GCN Sequence Number Description | drospirenone/estradiol TABLET 0.25-0.5MG ORAL |
| HIC3 | G1D |
| HIC3 Description | ESTROGEN-PROGESTIN WITH ANTIMINERALOCORTICOID COMB |
| GCN | 32417 |
| HICL Sequence Number | 039160 |
| HICL Sequence Number Description | DROSPIRENONE/ESTRADIOL |
| Brand/Generic | Brand |
| Proprietary Name | Angeliq |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | drospirenone and estradiol |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | .25; .5 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | DROSPIRENONE; ESTRADIOL |
| Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
| Pharmaceutical Class | Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA021355 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50419-0482-03 (50419048203)
| NDC Package Code | 50419-482-03 |
|---|---|
| Billing NDC | 50419048203 |
| Package | 3 BLISTER PACK in 1 CARTON (50419-482-03) / 28 TABLET, FILM COATED in 1 BLISTER PACK (50419-482-01) |
| Marketing Start Date | 2012-02-29 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |